Transradial approach in patients with ST-elevation myocardial infarction treated with abciximab results in fewer bleeding complications: data from EUROTRANSFER registry
| Autor: | Barbara Zawislak, Dariusz Dudek, Jacek S. Dubiel, Jacek Jakala, Stanislaw Bartus, Wojciech Zasada, Beata Noworolnik, Zbigniew Siudak, Tomasz Rakowski, Artur Dziewierz |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
Male
medicine.medical_specialty Blood transfusion Abciximab medicine.medical_treatment Myocardial Infarction Hemorrhage Punctures Femoral artery Risk Assessment Immunoglobulin Fab Fragments Hematoma Risk Factors medicine.artery Internal medicine Odds Ratio medicine Humans Blood Transfusion Registries cardiovascular diseases Myocardial infarction Angioplasty Balloon Coronary Stroke Aged Chi-Square Distribution business.industry Antibodies Monoclonal Percutaneous coronary intervention General Medicine Middle Aged medicine.disease Surgery Europe Femoral Artery Treatment Outcome surgical procedures operative Radial Artery Conventional PCI Cardiology Female Cardiology and Cardiovascular Medicine business Platelet Aggregation Inhibitors medicine.drug |
| Zdroj: | Coronary Artery Disease. 21:292-297 |
| ISSN: | 0954-6928 |
| Popis: | OBJECTIVES Our aim was to investigate the safety and efficacy of transradial approach, predictors of bleeding complications, and choice of radial access site in a real-life setting using a contemporary European registry of percutaneous coronary intervention (PCI) in ST-elevation myocardial infarction (STEMI). BACKGROUND There is an increasing amount of data suggesting that transradial approach is associated with less bleeding at access site and other vascular complications when compared with procedures carried out through the femoral artery. METHODS Consecutive data on STEMI patients transferred for primary PCI in hospital STEMI networks between November 2005 and January 2007 from seven countries in Europe were gathered. Patients were divided into the following two groups: radial approach - with radial access site for primary PCI, and transfemoral approach (FEM) - with femoral access site. RESULTS Data from a total of 1650 patients were collected in the EUROTRANSFER Registry. Abciximab was administered in 1086 patients (66%), 169 patients were assigned to radial approach group, whereas 917 to FEM group. Puncture site hematomas were more frequent in the FEM group (1.2 vs. 9.4%, P |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|